S&P 500   3,822.82 (-0.17%)
DOW   31,014.65 (-1.23%)
QQQ   316.30 (+1.11%)
AAPL   123.21 (+1.83%)
MSFT   233.40 (+1.93%)
FB   262.23 (+2.96%)
GOOGL   2,033.50 (+0.87%)
AMZN   3,081.08 (+0.78%)
TSLA   675.53 (-0.98%)
NVDA   548.14 (+2.98%)
BABA   240.74 (+0.23%)
CGC   32.56 (-1.96%)
GE   12.68 (-0.63%)
MU   91.71 (+4.07%)
NIO   46.49 (-0.68%)
AMD   84.43 (+2.44%)
T   28.03 (-2.10%)
F   11.77 (+0.09%)
ACB   10.71 (-1.02%)
DIS   189.64 (-0.70%)
BA   212.48 (-1.83%)
NFLX   542.98 (-0.68%)
BAC   34.93 (-2.78%)
S&P 500   3,822.82 (-0.17%)
DOW   31,014.65 (-1.23%)
QQQ   316.30 (+1.11%)
AAPL   123.21 (+1.83%)
MSFT   233.40 (+1.93%)
FB   262.23 (+2.96%)
GOOGL   2,033.50 (+0.87%)
AMZN   3,081.08 (+0.78%)
TSLA   675.53 (-0.98%)
NVDA   548.14 (+2.98%)
BABA   240.74 (+0.23%)
CGC   32.56 (-1.96%)
GE   12.68 (-0.63%)
MU   91.71 (+4.07%)
NIO   46.49 (-0.68%)
AMD   84.43 (+2.44%)
T   28.03 (-2.10%)
F   11.77 (+0.09%)
ACB   10.71 (-1.02%)
DIS   189.64 (-0.70%)
BA   212.48 (-1.83%)
NFLX   542.98 (-0.68%)
BAC   34.93 (-2.78%)
S&P 500   3,822.82 (-0.17%)
DOW   31,014.65 (-1.23%)
QQQ   316.30 (+1.11%)
AAPL   123.21 (+1.83%)
MSFT   233.40 (+1.93%)
FB   262.23 (+2.96%)
GOOGL   2,033.50 (+0.87%)
AMZN   3,081.08 (+0.78%)
TSLA   675.53 (-0.98%)
NVDA   548.14 (+2.98%)
BABA   240.74 (+0.23%)
CGC   32.56 (-1.96%)
GE   12.68 (-0.63%)
MU   91.71 (+4.07%)
NIO   46.49 (-0.68%)
AMD   84.43 (+2.44%)
T   28.03 (-2.10%)
F   11.77 (+0.09%)
ACB   10.71 (-1.02%)
DIS   189.64 (-0.70%)
BA   212.48 (-1.83%)
NFLX   542.98 (-0.68%)
BAC   34.93 (-2.78%)
S&P 500   3,822.82 (-0.17%)
DOW   31,014.65 (-1.23%)
QQQ   316.30 (+1.11%)
AAPL   123.21 (+1.83%)
MSFT   233.40 (+1.93%)
FB   262.23 (+2.96%)
GOOGL   2,033.50 (+0.87%)
AMZN   3,081.08 (+0.78%)
TSLA   675.53 (-0.98%)
NVDA   548.14 (+2.98%)
BABA   240.74 (+0.23%)
CGC   32.56 (-1.96%)
GE   12.68 (-0.63%)
MU   91.71 (+4.07%)
NIO   46.49 (-0.68%)
AMD   84.43 (+2.44%)
T   28.03 (-2.10%)
F   11.77 (+0.09%)
ACB   10.71 (-1.02%)
DIS   189.64 (-0.70%)
BA   212.48 (-1.83%)
NFLX   542.98 (-0.68%)
BAC   34.93 (-2.78%)
Log in
OTCMKTS:MTHRF

M3 Stock Forecast, Price & News

$78.51
0.00 (0.00 %)
(As of 02/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$78.51
Now: $78.51▼
$78.51
50-Day Range
$78.51
MA: $91.23▼
$102.00
52-Week Range
$23.93
Now: $78.51▼
$102.00
Volume200 shs
Average Volume600 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates m3.com, a members-only Web site for providing information to the healthcare professionals; and MR-kun that delivers medical and drug information online through m3.com. It also provides MDLinx that offers the review of medical articles and theses in English for physicians in the United States; and MEDI:GATE, which provides various medical news and content, and features online discussion boards where doctors can exchange opinions and communicate with one another in South Korea. In addition, the company offers various Internet-based services for pharmaceutical and other medical-related companies, including marketing support services for medical solution providers and healthcare professionals, clinical trial services, clinical trial support services, market research services, and doctor and pharmacist recruiting support services. Further, it provides services for general public, such as the operation of AskDoctors, a Q and A site to consult doctors through the Internet; Ichie Websites comprising Ichie Breast Cancer and Ichie Menopause, which offers insights and solutions related to breast cancer and menopause; and iTicket Plus, a reservation system for clinics through mobile phones and the Internet. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was founded in 2000 and is headquartered in Tokyo, Japan.

Headlines

Research Marketing And Advertising (RMA) Expands Marketing Services To Clinical Research Industry Nationwide
January 20, 2021 |  finance.yahoo.com
Omnicell Floating $500 Million Convertible Notes Issue
September 23, 2020 |  fool.com
Omnicell Announces Proposed Private Placement of $500 Million of Convertible Senior Notes
September 22, 2020 |  businesswire.com
U.S. Medication Adherence Packaging Industry Outlook, 2024 Featuring Omnicell, McKesson Corporation, Cardinal Health, and WestRock Company
August 10, 2020 |  prnewswire.com
Omnicell Streamlines Pharmacy Supply Chain Through Cloud-Based Predictive Intelligence Solution
July 20, 2020 |  www.businesswire.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Health Information Services
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MTHRF
Previous Symbol
CUSIPN/A
CIKN/A
Webcorporate.m3.com
Phone81 3 6229 8900
Employees7,127
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank™

Overall MarketRank™

1.00 out of 5 stars

Medical Sector

1012th out of 1,956 stocks

Health Information Services Industry

3rd out of 13 stocks

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$78.51
0.00 (0.00 %)
(As of 02/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MTHRF News and Ratings via Email

Sign-up to receive the latest news and ratings for MTHRF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











M3 (OTCMKTS:MTHRF) Frequently Asked Questions

Is M3 a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for M3 in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" M3 stock.
View analyst ratings for M3 or view top-rated stocks.

What stocks does MarketBeat like better than M3?

Wall Street analysts have given M3 a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but M3 wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting M3?

M3 saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 367,800 shares, an increase of 61.4% from the December 31st total of 227,900 shares. Based on an average trading volume of 200 shares, the days-to-cover ratio is currently 1,839.0 days.
View M3's Short Interest.

Who are M3's key executives?

M3's management team includes the following people:
  • Mr. Itaru Tanimura, Pres and Representative Director (Age 56)
  • Mr. Paul J. Rice, Chief Operating Officer of European Operations
  • Dr. Timothy Richard Ringrose MRCP, Chief Exec. Officer of M3 EU

Who are some of M3's key competitors?

Some companies that are related to M3 include 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), CloudMD Software & Services (DOCRF), CloudMD Software & Services (DOC), Cogstate (CGS), Corum Group (COO), EGF Theramed Health (EVAHF), Emyria Limited (EMD.AX) (EMD), eWellness Healthcare (EWLL), Global Health (GLH), ICS Global (ICS) and Jayex Healthcare (JHL).
View all of MTHRF's competitors.

What is M3's stock symbol?

M3 trades on the OTCMKTS under the ticker symbol "MTHRF."

How do I buy shares of M3?

Shares of MTHRF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is M3's stock price today?

One share of MTHRF stock can currently be purchased for approximately $78.51.

How many employees does M3 have?

M3 employs 7,127 workers across the globe.

What is M3's official website?

The official website for M3 is corporate.m3.com.

How can I contact M3?

The company can be reached via phone at 81 3 6229 8900.


This page was last updated on 2/26/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.